 |
 | Services
| |
 |
Aliases & Descriptions for NAT1
(According to
1HGNC,
2Entrez Gene,
3UniProtKB/Swiss-Prot,
4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc
, and/or 7Ensembl,
8miRBase) About This Section
|
| Aliases |
|---|
| AAC1 2, 3, 5 | | EC 2.3.1.5 3 | | MNAT 3 | | NAT-1 3 | | NATI 2 | | OTTHUMP00000122488 2 |
| | | Descriptions |
|---|
| Arylamide acetylase 1 3 | | Monomorphic arylamine N-acetyltransferase 3 | | N-acetyltransferase 1 2 | | N-acetyltransferase 1 (arylamine N-acetyltransferase) 2 | | N-acetyltransferase type 1 3 |
|
| | Search outside databases for aliases for NAT1 genePrevious GC identifers: GC08P017943 GC08P018130 GC08P018077 |
Summaries for NAT1(According to Entrez Gene,
Wikipedia's
Gene Wiki,
UniProtKB/Swiss-Prot,
and/or
UniProtKB/TrEMBL)
About This Section
| EntrezGene summary for NAT1: This gene is one of two arylamine N-acetyltransferase (NAT) genes in the human geneome, and is orthologous to the mouse and rat Nat2 genes. The enzyme encoded by this gene catalyzes the transfer of an acetyl group from acetyl-CoA to various arylamine and hydrazine substrates. This enzyme helps metabolize drugs and other xenobiotics, and functions in folate catabolism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq] UniProtKB/Swiss-Prot: ARY1_HUMAN, P18440Function: Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens |
Genomic Location for NAT1
(According to
GeneLoc and/or
HGNC, and/or
Entrez Gene (NCBI build 36),
and/or miRBase,
Genomic Views according to
UCSC and
Ensembl,
Transcription factor binding sites according to
SABiosciences) About This Section
| Genomic View: UCSC Golden Path with GeneCards custom track
Transcription factor binding sites upstream to the NAT1 gene 
Entrez Gene cytogenetic band: 8p23.1-p21.3 Ensembl cytogenetic band: 8p22 HGNC cytogenetic band: 8p22NAT1 Gene in genomic location: bands according to Ensembl, locations according to
(and/or Entrez Gene and/or Ensembl if different)
 GeneLoc gene densities for chromosome 8 GeneLoc Exon Structure GeneLoc location for GC08P018111:
(about GC identifiers)
Start:
|
18,111,895 bp from pter |
End:
|
18,125,100 bp from pter |
Size:
|
13,206 bases |
Orientation:
|
plus strand |
RefSeq DNA sequence:- NC_000008.9 NT_030737.9
| Proteins for NAT1
(According to
1UniProtKB,
and/or Ensembl,
Phosphorylation sites according to 2Phosphosite,
RefSeq according to NCBI,
PDB rendering according to OCA and/or Proteopedia,
Recombinant Proteins
from Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Enzo Life Sciences,
Abnova,
OriGene and/or,
Abcam,
Biochemical Assays by
Invitrogen,
Millipore,
R&D Systems,
Cell Signaling Technology, and/or
Enzo Life Sciences,
Ontologies according to Gene
Ontology Consortium 01 Apr 2009 and
Entrez Gene,
Antibodies by Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Cell Signaling Technology,
Abcam,
Abnova, and/or
Novus Biologicals)
About This Section
| UniProtKB/Swiss-Prot: ARY1_HUMAN, P18440 (See
protein sequence)Recommended Name: Arylamine N-acetyltransferase 1 Size: 290 amino acids; 33899 Da
Subcellular location: Cytoplasm
Miscellaneous: NAT1 was historically considered to be monomorphic in nature but reports of allelic variations at the NAT1 locus suggest that it is a polymorphically expressed enzyme
Caution: The allelic variation Ile-149 designated as NAT1*17 is part of the NAT1*11 allelic variation as reported by the nomenclature commitee
PDB structures from and Proteopedia :2DSS (3D)
 2GWU (3D)
 2IJA (3D)
 2PQT (3D)
 
Secondary accessions: A8K4E7 O15159 O15300 Q546N1 Q96TE9Post-translational modifications:
View phosphorylation sites using PhosphoSite2
REFSEQ proteins (9 alternative transcripts):
NP_000653.3 NP_001153642.1 NP_001153643.1 NP_001153644.1 NP_001153645.1 NP_001153646.1 NP_001153647.1 NP_001153648.1 NP_001153651.1
ENSEMBL proteins: ENSP00000307218
Human Recombinant Proteins Browse Origene for full length recombinant human proteins expressed in human HEK293 cells 
2 Gene Ontology (GO) cellular component terms (links to tree view): About this table
Antibodies for NAT1: Assays for NAT1: | Protein
Domains/ Families for NAT1(According to InterPro, ProtoNet,
UniProtKB, and/or BLOCKS,
Sets of similar genes according to GeneDecks)
About This Section
| - Graphical View of Domain Structure for InterPro Entry P18440
ProtoNet protein and cluster: P18440 1 Blocks protein family: IPB004081 Arylamine N-acetyltransferase signature
UniProtKB/Swiss-Prot: ARY1_HUMAN, P18440Similarity: Belongs to the arylamine N-acetyltransferase family | Gene Function for NAT1
(According to MGI Jun 06 2009, UniProtKB,
IUBMB,and/or Genatlas,
shRNA from
OriGene,
Sigma-Aldrich, RNAi from
Sigma-Aldrich,
RNAi Products,
Clones, and
Q-PCR Products
from Invitrogen,
Millipore,
OriGene, and/or
Abnova,
siRNAs from
Applied Biosystems,
SYBR primers from OriGene,
Cell-based Assays from Millipore,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_000662
Applied Biosystems Silencer® siRNAs for NAT1
Sigma-Aldrich siRNA for NAT1  Sigma-Aldrich shRNA for NAT1  Explore Sigma-Aldrich super-pooled esiRNAs 
              OriGene GFP tagged cDNA clone in CMV expression vector: NM_000662                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_000662                                  untagged cDNA clone in CMV expression vector: NM_000662 
Primers: Browse
Quantitative PCR Central at Invitrogen for Q-PCR LUX™ Primers               OriGene genome-wide validated SYBR primer pairs: NM_000662
UniProtKB/Swiss-Prot: ARY1_HUMAN, P18440Function: Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogensCatalytic activity: Acetyl-CoA + an arylamine = CoA + an N-acetylarylamineEnzyme Number (IUBMB): EC 2.3.1.5 Genatlas biochemistry entry for NAT1:arylamine N-acetyltransferase 1,widely expressed,monomorphic,also involved in bladder carcinogenesis5 MGI mutant phenotypes (inferred from 2 alleles ) (MGI details for Nat2):
3 Gene Ontology (GO) molecular function terms (links to tree view): About this table | Pathways & Interactions for NAT1
(Pathways according to Invitrogen
(maps by GeneGo),
Millipore,
Cell Signaling Technology,
Sigma-Aldrich,
KEGG
and/or UniProtKB,
Sets of similar genes according to GeneDecks,
Proteins Network according to
SABiosciences,
Interactions according to 1UniProtKB,
2MINT, and/or
3STRING,
with links to IntAct and
Ensembl,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|
Gene Network CentralTM Interacting Genes and Proteins Network for NAT1 
1 Gene Ontology (GO) biological process term (links to tree view): | GO ID | Qualified GO term | Evidence | PubMed IDs |
|---|
| GO:0008152 | metabolic process |
IEA | -- | About this table
|
Drugs & Compounds for NAT1(Chemical Compounds according to UniProtKB, Enzo Life Sciences,
Sigma-Aldrich, Tocris Bioscience, and/or
Novoseek and Drugs according to
Enzo Life Sciences and/or
PharmGKB)
About This Section
|
Browse Tocris compounds for NAT1 10/26 Novoseek chemical compound relationships for NAT1 gene (see all 26
)
| Compound |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| arylamine |
97.50 |
164 |
8861781 (6), 11436130 (3), 9511183 (2), 16829624 (2) (see all 82) |
| 2-aminofluorene |
89.61 |
10 |
16314733 (1), 16829624 (1), 8179482 (1), 9571233 (1) (see all 9) |
| p-acetamidobenzoylglutamate |
80.81 |
3 |
9839355 (1), 11113560 (1) |
| n-hydroxy-2-aminofluorene |
80.81 |
4 |
8425184 (3), 8353847 (1) |
| 2-naphthylamine |
77.13 |
1 |
8353847 (1) |
| phip |
76.87 |
5 |
8179482 (1), 10381774 (1), 12618593 (1), 14601045 (1) |
| 2-amino-3-methylimidazo(4,5-f)quinoline |
72.94 |
3 |
16496416 (1), 8353847 (1), 1423830 (1) |
| n-hydroxy-2-acetylaminofluorene |
70.75 |
5 |
8425184 (3), 15025497 (1), 8353847 (1) |
| meiqx |
70.24 |
6 |
8179482 (1), 8012961 (1), 11875368 (1) |
| n-hydroxy phip |
68.48 |
2 |
11505221 (1) |
About this table
2 PharmGKB drug compound relationships for NAT1 geneAbout this table
|
Transcripts for NAT1(GenBank/EMBL/DDBJ Accessions according to
Unigene
(Build 219 Homo sapiens; Jun 2 2009) or GenBank, RefSeq according to Entrez Gene,
DOTS (version 10), and/or
AceView,
non coding RNAs according to
RNAdb,
ESTs according to GeneTide,
exon structure from GeneLoc,
alternative splicing isoforms according to ASD and/or
ECgene,
RNAi Products from Invitrogen,
Millipore, and/or
Abnova,
siRNAs from Applied Biosystems,
Sigma-Aldrich,
shRNA from
Sigma-Aldrich,
OriGene,
Tagged/untagged cDNA clones from
OriGene) About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_000662
Sigma-Aldrich siRNA for NAT1  Sigma-Aldrich shRNA for NAT1  Explore Sigma-Aldrich super-pooled esiRNAs 
Applied Biosystems Silencer® siRNAs: NM_000662 REFSEQ mRNAs for NAT1 gene (9 alternative transcripts): NM_000662.5 NM_001160170.1 NM_001160171.1 NM_001160172.1 NM_001160173.1 NM_001160174.1 NM_001160175.1 NM_001160176.1 NM_001160179.1 NM_000662               OriGene GFP tagged cDNA clone in CMV expression vector: NM_000662                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_000662                                  untagged cDNA clone in CMV expression vector: NM_000662  Additional cDNA sequence: AJ581135.1 AJ581136.1 AJ581137.1 AJ581138.1 AJ581139.1 AJ581140.1 AJ581141.1 AJ581142.1 AJ581143.1 AJ581151.2 AJ581153.1 AJ581154.1 AJ581155.1 AK290912.1 BC013732.1 BC047666.1 BX647521.1 CR596299.1 D90041.1 S78829.1 10 DOTS entries: DT.95269815 DT.212955 DT.121491296 DT.75190644 DT.121491283 DT.100746983 DT.40261666 DT.92018326 DT.97824906 DT.121491295 24/65 AceView cDNA sequences (see all 65
):BQ231158 BF594441 CR596299 BM926650 D78248 BG941635 NM_000662 BQ024509 BF034718 BC047666 BG654454 BM924372 T29485 D90041 BU753390 CB852436 AI022585 AI888631 BU689480 BX112361 BX647521 BC013732 CD511345 BG656530
highest scoring ESTs for NAT1:D90041 AA721180 AA913774 AI022585 AI204592 AI673244 AI861954 AI888631 AW071050 AW071587 Unigene Cluster for NAT1: N-acetyltransferase 1 (arylamine N-acetyltransferase) Hs.591847 [show with all ESTs]Unigene Representative Sequence: BC013732
GeneLoc Exon Structure
5/9 Alternative Splicing Database (ASD) splice patterns (SP) for NAT1 (see all 9
)
| ExUns: | 1 | ^ | 2a | · | 2b | ^ | 3a | · | 3b | ^ | 4a | · | 4b | ^ | 5 | ^ | 6 | ^ | 7a | · | 7b | · | 7c | · | 7d | · | 7e | · | 7f | |
| SP1: | |   | - |   | - |   | - |   | - |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP2: | |   | |   | |   | - |   | - |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP3: | |   | |   | |   | - |   | - |   | |   | |   | - |   | |   | |   | |   | |   | |   | |   | |   | |
| SP4: | |   | |   | |   | |   | |   | - |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |   | |
| SP5: | |   | |   | |   | |   | |   | |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |   |
About this scheme
ECgene alternative splicing isoforms for NAT1
1 Ensembl transcript including schematic representation: ENST00000307719
|
Expression for NAT1
(Experimental results according to
1GeneNote
and GNF BioGPS,
probe sets-to-genes annotations according to
2GeneAnnot ,
3GeneTide ,
Sets of similar genes according to GeneDecks,
Electronic Northern calculations according to data from
UniGene (Build 219 Homo sapiens),
SAGE tags according to
CGAP,
plus additional links to
SOURCE, and/or
GNF
BioGPS, and/or
EXPOLDB, and/or
UniProtKB,
Expression Assays from
Applied Biosystems
)
About This Section
| NAT1 expression in normal and diseased human tissues
Applied Biosystems TaqMan ® Gene Expression Assays for NAT1
1 / 2 / 3 4 probe-sets matching NAT1 gene Data from
(Publications) and GNF BioGPS About these images About these images
CGAP SAGE TAG: TATCTTCTGT
SOURCE GeneReport for Unigene cluster: Hs.591847
Expression variation in blood from EXPOLDB for NAT1 |
Orthologs for NAT1
(Orthologs according to
1,2HomoloGene (2older version, for species not in 1newer version),
3euGenes,
4SGD
and/or
5MGI Jun 06 2009,
with possible further links to
Flybase
and/or
WormBase,
Gene Trees according to Ensembl)
About This Section
|
Orthologs for NAT1 gene from 5/6 species (see all 6
)
About this table Species with no ortholog for NAT1
ENSEMBL Gene Tree for NAT1 | Paralogs for NAT1(Paralogs according to 1HomoloGene and 2Ensembl, Pseudogenes according to 3Pseudogene.org) About This Section
| Paralogs for NAT1 gene
- NAT22
Pseudogenes
- 1 related pseudogene
|
SNPs/Variants for NAT1(According to the
1NCBI SNP Database,
2Ensembl,
3PupaSUITE, and
UniProtKB,
Linkage Disequilibrium by HapMap,
Genotyping Reagents from
Applied Biosystems)
About This Section
| UniProtKB/Swiss-Prot: ARY1_HUMAN, P18440Polymorphism: N-acetylation polymorphism is determined by a low or high NAT activity in liver and has been implicated in the action and toxicity of amine-containing drugs. Slow acetylation genotypes have been associated with significant lung cancer risk. Candidate risk factor for susceptibility to neural tube defects. The NAT1*10 allele has been associated with increased risk of colon and urinary bladder cancers and with higher levels of N-acetyltransferase activity and DNA adducts in aromatic amine tumor target organs such as colon and urinary bladder
HapMap Linkage Disequilibrium images for NAT1 (up to first 250kb)
|
Disorders & Mutations for NAT1
(in which this Gene is Involved, According to
OMIM, UniProtKB,
Novoseek, PharmGKB,
Genatlas, GeneTests,
Blood group antigen gene mutations by BGMUT,
HGMD, GAD,
HuGE Navigator,
BCGD,
and/or TGDB.)
About This Section
|
OMIM: 108345
10/36 Novoseek disease relationships for NAT1 gene (see all 36
)
| Disease |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| bladder cancer |
71.14 |
38 |
11431340 (4), 9107426 (4), 14564055 (4), 17026750 (2) (see all 17) |
| colorectal cancer |
55.74 |
38 |
16434594 (5), 7627961 (4), 9528834 (3), 15736440 (3) (see all 14) |
| cancer |
51.56 |
76 |
10667461 (5), 12351146 (3), 18259988 (2), 14672957 (2) (see all 44) |
| genetic susceptibility |
49.45 |
5 |
18259988 (1), 10667461 (1), 12485520 (1) |
| pancreatic cancer |
27.81 |
14 |
15987714 (4), 18006927 (2), 9696930 (1), 11095579 (1) (see all 5) |
| colon cancer |
27.00 |
13 |
18022202 (4), 18569593 (2), 12568823 (1), 10493262 (1) |
| neural tube defects |
26.85 |
2 |
10767335 (1) |
| lymphoblastic leukemia acute childhood |
26.79 |
1 |
10868688 (1) |
| breast cancer |
25.52 |
45 |
12860276 (4), 10090301 (3), 17973251 (3), 15090724 (3) (see all 17) |
| cancer lung |
24.83 |
17 |
9731715 (4), 9626964 (3), 16835348 (1), 18258609 (1) (see all 6) |
About this table
1 PharmGKB disease relationship for NAT1 geneAbout this table
Human Gene Mutation Database: NAT1 Genetic Association Database: NAT1 Human Genome Epidemiology Navigator: NAT1 (176 documents)
|
Medical News for NAT1(Possibly Related Articles in
Doctor's Guide)
About This Section
| |
Publications for NAT1 (in
PubMed.
Associations of this gene to articles via
1Novoseek,
2HGNC,
3Entrez Gene,
4UniProtKB/Swiss-Prot,
5UniProtKB/TrEMBL,
6GAD, and/or
7PharmGKB)
About This Section
| 10/341 PubMed articles for NAT1 gene (see all 341
):- Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations. (PubMed id 9511183)1, 3, 4 Butcher N.J.... Minchin R.F. (1998)
- NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant. (PubMed id 15142281)1, 3, 6 Johnson N....Sim E. (2004)
- Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. (PubMed id 15725609)1, 3, 6 Gu J....Wu X. (2005)
- N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer. (PubMed id 12860276)1, 3, 6 Lee K.M....Kang D. (2003)
- Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study. (PubMed id 12355549)1, 3, 6 Hein D.W....Caporaso N.E. (2002)
- [The research the relationship between N-acetyltransferase 1 gene polymorphisms and genetic susceptibility to sporadic colorectal adenocarcinoma] (PubMed id 12485520)1, 3, 6 Zhang Y....Zhou Y. (2002)
- Association of arylamine N-acetyltransferase (NAT1 and NAT2) genotypes with urinary bladder cancer risk. (PubMed id 14564055)1, 3, 6 Jaskul/a-Sztul R....Szyfter K. (2001)
- Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. (PubMed id 11431340)1, 3, 6 Cascorbi I....Brockmoller J. (2001)
- Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. (PubMed id 8442668)1, 3, 4 Vatsis K.P. and Weber W.W. (1993)
- Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. (PubMed id 15987714)1, 3, 6 Li D....Hassan M.M. (2006)
|
Search for NAT1
(in PubMed,
OMIM, and NCBI Bookshelf) About This Section
|
|
Genome Databases showing NAT1
(According to
Entrez Gene,
HGNC,
AceView,
euGenes,
Ensembl,
miRBase,
ECgene,
and/or
H-InvDB)
About This Section
|
| Other Databases showing NAT1
(According to HUGE)
About This Section
| -- |
Specialized Databases showing NAT1(According to ATLAS, HORDE, IMGT, MTDB, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL, Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot) About This Section
|
| Name | Description |
| ATLAS Chromosomes in Cancer entry for NAT1 | Genetics and Cytogenetics in Oncology and Haematology | | NAT | http://www.louisville.edu/medschool/pharmacology/NAT.html | | NIEHS-SNPs | http://egp.gs.washington.edu/data/nat1/ | | SHMPD | http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=NAT1 |
|
| | | About This Section
| --
| Services for NAT1(Reagents available from Applied Biosystems, Antibodies and assays by Cell
Signaling Technology, Abcam, Novus Biologicals, Sigma-Aldrich, R&D Systems, Millipore, Abnova, and/or Invitrogen, Clones available from OriGene,and/or Invitrogen, Drugs and/or compounds by Sigma-Aldrich, Enzo Life Sciences, and/or Tocris Bioscience) About This Section
| 
 Products for NAT1:

 | |
 | | | | |
|
 |  |  |
| | Recombinant Proteins (NAT1) | | Antibodies (NAT1) |
| | | Search Tocris compounds for NAT1 |
|
 |
 | | | |
GeneCards Homepage - Last full update: 1 Jul 2009
Incremental update: 13 Oct 2009
|